[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Envoy Medical Inc (COCH)

Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 50,834
  • Shares Outstanding, K 76,881
  • Annual Sales, $ 240 K
  • Annual Income, $ -23,760 K
  • EBIT $ -23 M
  • EBITDA $ -22 M
  • 60-Month Beta 1.90
  • Price/Sales 223.62
  • Price/Cash Flow N/A
  • Price/Book 5.30
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.04
  • Most Recent Earnings $-0.11 on 05/11/26
  • Next Earnings Date 07/30/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.08
  • Number of Estimates 1
  • High Estimate $-0.08
  • Low Estimate $-0.08
  • Prior Year $-0.32
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6300 +4.95%
on 05/11/26
0.7675 -13.85%
on 05/19/26
-0.0358 (-5.14%)
since 05/05/26
3-Month
0.6011 +10.00%
on 04/10/26
0.9539 -30.68%
on 03/17/26
-0.0322 (-4.64%)
since 03/05/26
52-Week
0.3625 +82.40%
on 02/11/26
1.8900 -65.02%
on 10/07/25
-0.7288 (-52.43%)
since 06/05/25

Most Recent Stories

More News
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET

Featured Interviews Include Envoy Medical (NASDAQ:COCH), Big Sky Industrial (NASDAQ:BSIN), Graphene Manufacturing Group (OTCQX:GMGMF), Gold Royalty Corp. (NYSE American:GROY), and New York City's Acclaimed...

RDZN : 1.7100 (-9.76%)
CAST : 0.6775 (-7.06%)
GROY : 2.83 (-9.00%)
GMGMF : 1.7500 (-5.91%)
LTRN : 3.59 (-5.28%)
MDCX : 0.3500 (-6.32%)
DVLT : 0.4294 (-8.01%)
COCH : 0.6612 (-5.68%)
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th

White Bear Lake, Minnesota--(Newsfile Corp. - June 4, 2026) - Envoy Medical® Inc. (NASDAQ: COCH), a hearing health company pioneering fully implanted hearing solutions, today announced that Brent Lucas,...

COCH : 0.6612 (-5.68%)
Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street

Envoy Medical to Launch National Media Awareness Campaign Highlighting a Global Hearing-Loss Market Affecting More Than 1.5 Billion People Worldwide

COCH : 0.6612 (-5.68%)
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology

Australian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in Implantable System Design, Signal Analysis, and Battery Recharge SafetyWhite Bear Lake, Minnesota--(Newsfile...

COCH : 0.6612 (-5.68%)
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant

Company Completes Historic Trial Enrollment, Secures Transformational Financing, and Sees Promising Early Clinical Data Presented at Industry ConferencesWhite Bear Lake, Minnesota--(Newsfile Corp. - May...

COCH : 0.6612 (-5.68%)
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Quality of Life Scores Presented; Additional Presentations Scheduled in Early MayDetails to be Discussed...

COCH : 0.6612 (-5.68%)
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

All 56 Enrolled Subjects Have Been Through Their Activation Visit Firming Up Study TimelineWhite Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"...

COCH : 0.6612 (-5.68%)
Envoy Medical Appoints Chas McKhann to Board of Directors

Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful ExitsWhite Bear Lake, Minnesota--(Newsfile Corp....

COCH : 0.6612 (-5.68%)
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

Company Remains on Schedule for PMA Submission to FDAWhite Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering...

COCH : 0.6612 (-5.68%)
Envoy Medical Reports Full Year 2025 Financial Results

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end, closed...

COCH : 0.6612 (-5.68%)

Business Summary

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

See More

Key Turning Points

3rd Resistance Point 0.7236
2nd Resistance Point 0.7067
1st Resistance Point 0.6839
Last Price 0.6612
1st Support Level 0.6442
2nd Support Level 0.6273
3rd Support Level 0.6045

See More

52-Week High 1.8900
Fibonacci 61.8% 1.3065
Fibonacci 50% 1.1263
Fibonacci 38.2% 0.9460
Last Price 0.6612
52-Week Low 0.3625

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.